What Does Endo Pharmaceuticals Do?

Total employees538
HeadquartersDublin
Founded

Endo International plc is a specialty pharmaceutical company focused on developing, manufacturing, marketing, and distributing high-value branded and generic pharmaceutical products. The company aims to improve patients' lives by providing quality medicines and addressing unmet medical needs, primarily in the United States. Following a financial restructuring, Endo emerged from Chapter 11 in April 2023 as a private company owned by its former first-lien lenders.

Where Is Endo Pharmaceuticals's Headquarters?

HQ Function

Serves as the official registered office and global corporate headquarters, responsible for corporate governance, strategic oversight, and international financial management.

Notable Features:

Modern office facility located in a prominent business district, designed to support global administrative and strategic operations.

Work Culture:

The corporate culture is expected to be focused on pharmaceutical innovation, regulatory compliance, ethical practices, and driving growth. Post-restructuring, there is likely a strong emphasis on efficiency, financial discipline, and rebuilding value.

HQ Significance:

The Dublin headquarters is strategically important for Endo's international corporate structure, governance, and global financial operations. It signifies its status as a global pharmaceutical entity.

Values Reflected in HQ: The headquarters reflects a commitment to global operations and strategic financial management. Core company values typically include a focus on patients, integrity, collaboration, and innovation in delivering healthcare solutions.

Location:

While Endo International plc is headquartered in Dublin, Ireland, its primary commercial and operational focus is concentrated in the United States. Global functions supported include corporate strategy and governance from Ireland, with extensive U.S.-based operations covering research & development, manufacturing of specialty branded and generic pharmaceuticals, and comprehensive commercialization activities. The company also has manufacturing facilities and may engage in international partnerships or licensing for specific products beyond the U.S.

Street Address:

First Floor, Minerva House, Simmonscourt Road, Ballsbridge

City:

Dublin

State/Province:

D04 E5T6

Country:

Ireland

Where Else Does Endo Pharmaceuticals Operate Around the World?

Malvern, Pennsylvania, USA

Address: 1400 Atwater Dr, Malvern, PA 19355, USA

Manages and executes the company's strategy for the U.S. pharmaceutical market, overseeing the development, manufacturing, marketing, and sales of branded and generic products in the region.

Chestnut Ridge, New York, USA

Address: 6 Ram Ridge Road, Chestnut Ridge, NY 10977, USA

Supports Endo's generics business segment (Par Pharmaceutical) with manufacturing capabilities and product development for the U.S. market.

Buying Intent Signals for Endo Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Endo Pharmaceuticals? Meet the Executive Team

As of April 2025, Endo Pharmaceuticals' leadership includes:

Blaise Coleman - President and Chief Executive Officer
Mark T. Bradley - Executive Vice President and Chief Financial Officer
Patrick Barry - Executive Vice President and President, Global Commercial Operations
John K. Grady - Executive Vice President, Chief Legal Officer
Flonase Matt - Executive Vice President & Chief Human Resources Officer

Who's Investing in Endo Pharmaceuticals?

Endo Pharmaceuticals has been backed by several prominent investors over the years, including:

Endo International plc became a private company in April 2023. It is now owned by a consortium of its former first-lien debtholders. Key firms that were part of the ad hoc group of first-lien lenders involved in taking ownership include Silver Point Capital, L.P., Blackstone, Carlyle, and Oaktree Capital Management.

What Leadership Changes Has Endo Pharmaceuticals Seen Recently?

Hire0
Exits0

Following its emergence from Chapter 11 restructuring in April 2023, Endo International plc confirmed its key leadership team. The past 12 months have focused on operational stability and growth for the new private entity, with the existing leadership largely transitioning with the restructured company. No major high-profile external hires or departures from the core executive team have been publicly announced in this period.

What Technology (Tech Stack) Is Used byEndo Pharmaceuticals?

Discover the tools Endo Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Endo Pharmaceuticals Email Formats and Examples

Endo International plc, like many corporations, uses standardized email formats. The most common formats are typically a combination of the employee's first name, last name, or initials with the company domain '@endo.com'.

[first_initial][last_name]@endo.com (e.g., jsmith@endo.com) and [first_name].[last_name]@endo.com (e.g., john.smith@endo.com) are common structures.

Format

bcoleman@endo.com or blaise.coleman@endo.com

Example

80%

Success rate

What's the Latest News About Endo Pharmaceuticals?

PR Newswire / Endo International plcApril 25, 2023

Endo International plc Successfully Completes Financial Restructuring and Emerges from Chapter 11

Endo International plc announced its emergence from Chapter 11 proceedings, having completed its financial restructuring. The company is now a private entity, owned by its former first-lien debtholders, and is focused on its mission of providing essential medicines to patients....more

Endo International plc Press ReleaseOctober 3, 2023

Endo Announces FDA Approval and Launch of an Additional Dosage Strength of XTAMPZA® ER (oxycodone) CII with Co-Packaged NALOXONE HCL Nasal Spray

Endo International plc announced that its operating company, Endo Pharmaceuticals Inc., received U.S. Food and Drug Administration (FDA) approval for an additional 13.5 mg dosage strength of XTAMPZA ER (oxycodone extended-release capsules) with separately co-packaged naloxone hydrochloride nasal spray and has commenced shipment to wholesalers....more

ReutersMarch 17, 2023

U.S. judge OKs Endo bankruptcy plan that settles opioid lawsuits

A U.S. bankruptcy judge approved Endo International's bankruptcy restructuring plan, which included a settlement of widespread lawsuits alleging the company fueled the U.S. opioid epidemic. The plan outlined payments to an opioid settlement trust and a transfer of company ownership to lenders....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Endo Pharmaceuticals, are just a search away.